Michael Balatico
No Rating Available
(Learn About Our Rating System)

Michael Balatico, MFA, MD

Languages spoken: English

  • Specialties

    • Pathology, Anatomical

    Board Certification

    American Board of Pathology (Sub: Cytopathology)
    American Board of Pathology (Anatomic & Clinical)

  • Board Certification and Academic Information

    Academic Departments Pathology -Assistant Professor (Clinical)
    Board Certification
    American Board of Pathology (Sub: Cytopathology)
    American Board of Pathology (Anatomic & Clinical)

    Education history

    Undergraduate Literary Arts - Brown University B.A.
    Graduate Training Creative Writing - School of the Art Institute of Chicago M.F.A.
    Professional Medical Medicine - Indiana University School of Medicine M.D.
    Residency Anatomic & Clinical Pathology - University of Utah School of Medicine Resident
    Fellowship Cytopathology - University of Utah School of Medicine Fellow

    Selected Publications

    Journal Article

    1. Badve SS, Dougherty R, Balatico M, Kesler KA, Loehrer P, Gökmen-Polar (2021). Thymic Carcinomas and Second Malignancies: A Single-Center Review. Cancers, 13(10), (Read full publication)
    2. Smith EA, Belote RL, Cruz NM, Moustafa TE, Becker CA, Jiang A, Alizada S, Prokofyeva A, Chan TY, Seasor TA, Balatico M, Cortes-Sanchez E, Lum DH, Hyngstrom JR, Zeng H, Deacon DC, Grossmann AH, White RM, Zangle TA, Judson-Torres R (2024). Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment. Journal of experimental & clinical cancer research, 43(1), 317. (Read full publication)
    3. Mahlow J, Barry M, Albertson DJ, Jo YJ, Balatico M, Seasor T, Gebrael G, Kumar SA, Sayegh N, Tripathi N, Agarwal N, Swami U, Sirohi (2024). Histologic patterns in prostatic adenocarcinoma are not predictive of mutations in the homologous recombination repair pathway. Human pathology, 144, 28-33. (Read full publication)
    4. Wilcock D, Sirohi D, Coleman JF, Adelhardt P, Kim JT, Albertson D, Affolter K, Beech C, Jedrzkiewicz J, Ruano AL, Cleary AS, Mahlow J, Balatico M, Gulbahce H (2025). HER2 fluorescence in situ hybridization groups 2-4 breast cancers classified as positive after targeted recounts following equivocal (2+) immunohistochemistry. American journal of clinical pathology, 163(6), 837-846. (Read full publication)
    5. Hutman-Zahler A, Goldstein J, Anderson T, Balatico M, Brophy DR, Aoki J, Miller K, Kovach K, Jacobsen A, Carter (2025). A Rare Case of Fulminant Myocarditis Leading to the Diagnosis of Systemic Lupus Erythematosus. JACC. Case reports, 30(19), 104049. (Read full publication)
    6. Perez-Gutierrez VA, Ahmed M, Krishna B G, Hird K, Balatico M, Waqar MA, Chambers J, Ansari S (2025). Extracranial Spread of Meningiomas: Molecular Determinants, Diagnostic Pathways, and Lessons from Three Thoracic Metastases. . Cureus,

    Letter

    1. Kator S, Zurko J, Webb BJ, Balatico MA, Clayton F, Palmer CA, Konopa K, Motyckova G, Ford CD, Ostronoff F (2020). Disseminated toxoplasmosis and haemophagocytic lymphohistiocytosis following chimeric antigen receptor T-cell therapy. [Letter to the editor]. Br J Haematol, 189(1), e4-e6. (Read full publication)
    2. Balatico M, Ruano AL, Cleary AS, Lomo L, Gulbahce H (2024). Male Invasive Lobular Breast Cancer: Clinicopathologic Features Including Recurrence Score Results From a Population-Based Database. Archives of pathology & laboratory medicine, 148(3), 263-264. (Read full publication)